483-17-0

83968-54-1 trilithium 2-[2-(4-nitro-2-sulphonatophenyl)vinyl]-5-[[4-[(4-sulphonatophenyl)azo]phenyl]-O,N,N-azoxy]benzenesulphonate

483-17-0 cephaeline

483-19-2 emetamine

20183-47-5 2β,27-Dihydroxy-3β-(β-D-glucopyranosyloxy)oleana-12-ene-23,28-dioic acid

17839-22-4 2,3-DICHLOROPROPIONANILIDE

483-64-7 DAMASCENINE

623177-14-0 7-CHLORO-2-METHYL-1H-INDOLE

201654-33-3 3',4'-dihydro-1'H-spiro[cyclohexane-1,2'-quinolin]-7'-aMine

483366-12-7 1-Pyrroli

62224-24-2 METHYL4,5-DIBROMOTHIOPHENE-2-CARBOXYLATE

201856-48-6 (3R,4S)-3-(1-Ethoxyethoxy)-4-phenyl-2-azetidinone

178422-42-9 Cefdinir Related Compound A (10 mg) (2(R)-2-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido]-2-[(2RS,5RS)-5-methyl-7-oxo-2,4,5,7-tetrahydro-1Hfuro[3,4-d][1,3]thiazin-2-yl]acetic acid)

201864-00-8 (S)-2-amino-3-(4-chlorophenyl)propan-1-ol

4835-39-6 4-nitroacetoacetanilide

201863-98-1 (S)-4-Amino-4-phenylbutyric acid

178388-79-9 3-(1H-IMIDAZOL-2-YL)-PROPIONIC ACID

88917-25-3 Poly(oxy-1,4-butanediyl), .alpha.-hydro-.omega.-hydroxy-, polymer with 2,4-diisocyanato-1-methylbenzene, 2-hydroxyethyl acrylate-blocked poly(oxy-1,4-butanediyl), alpha-hydro- omega -hydroxy-, polymer with 2,4-diisoc

483-55-6 2-hydroxy-3-methyl-1,4-naphthoquinone

83969-11-3 2-[2-[4-(diethylammonio)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium oxalate

839708-50-8 5-PyriMidinecarboxaldehyde, 2-chloro-4-(MethylaMino)-